1) To assess the technical feasibility we established an internal testing procedure comprising the following tests to be performed on the prototype, dedicated to i) verify the functionality of every module of the software including the Graphical User Interface (GUI); ii) test the software performances in terms of its capabilities to reproduce experimental data, i.e. electrical curves measured on electronic device and to interpret the electrical curves in terms of the device material and geometry properties, and iii) test the computational efficiency (e.g. speed, convergence) and intuitiveness of the GUI. In addition, MDLab provided Ginestra software to some customers (in Europe, USA and Taiwan) in order to be used and tested by them so as to return their feedbacks, through ad hoc questionnaires, on the product performance in terms of software installation/update, software usage and technical support. Both internal and external tests have confirmed the technical feasibility of Ginestra and its superiority compared to existing TCAD products.
2) We carried out a market analysis –comprising risks and sensitivity analysis- to verify Ginestra economic viability in terms of market trends, competitors and competitive solutions, potential customers identification/description as well as exploitation model. Moreover, we developed a detailed Business Plan for the next 5 years, attached.
The outcome from these studies is significant with regard to:
• market growth: 11.9% from 2013 to 2014 (with a significant share in Europe).
• competitors and their solutions: there are no available products able to compete with Ginestra in terms of usage scope, technical features, user-friendliness).
• capability to respond to identified market (potential customers) needs.
